Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production

Rinki Ray, Christine M. Herring, Troy A. Markel, Paul R. Crisostomo, Meijing Wang, Brent Weil, Tim Lahm, Daniel R. Meldrum

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Modulating the paracrine effects of bone marrow mesenchymal stem cells (BMSCs) may be important for the treatment of ischemic myocardial tissue. In this regard, endogenous estrogen may enhance BMSC vascular endothelial growth factor (VEGF) production. However, little information exists regarding the effect of testosterone on stem cell function. We hypothesized that 1) endogenous or exogenous estrogen will enhance stem cell production of VEGF and 2) endogenous or exogenous testosterone will inhibit BMSC VEGF production. BMSCs were collected from adult male, female, castrated male, and ovariectomized female rats. One hundred thousand cells were incubated with testosterone (1, 10, or 100 nM) or estrogen (0.15, 1.5, or 15 nM) for 48 h. Cell supernatants were collected, and VEGF was measured by ELISA. BMSCs harvested from castrated males, normal females, and ovariectomized females produced more VEGF compared with normal males. Castration was associated with the highest level (1,018 ± 98.26 pg/ml) of VEGF production by BMSCs, which was significantly more than that produced by BMSCs harvested from normal male and normal female animals. Exogenous testosterone significantly reduced VEGF production in BMSCs harvested from ovariectomized females in a dose-dependent manner. Exogenous estrogen did not alter BMSC VEGF production. These findings suggest that testosterone may work on BMSCs to decrease protective growth factor production and that effective removal of testosterone's deleterious effects via castration may prove to be beneficial in terms of protective factor production. By manipulating the mechanisms that BMSCs use to produce growth factors, we may be able to engineer stem cells to produce maximum growth factors during therapeutic use.

Original languageEnglish
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume294
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Mesenchymal Stromal Cells
Vascular Endothelial Growth Factor A
Testosterone
Bone Marrow
Estrogens
Intercellular Signaling Peptides and Proteins
Stem Cells
Castration
Therapeutic Uses
Enzyme-Linked Immunosorbent Assay

Keywords

  • Androgens
  • Castration
  • Estrogen
  • Ovariectomy
  • Sex
  • Sex hormones

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production. / Ray, Rinki; Herring, Christine M.; Markel, Troy A.; Crisostomo, Paul R.; Wang, Meijing; Weil, Brent; Lahm, Tim; Meldrum, Daniel R.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 294, No. 5, 05.2008.

Research output: Contribution to journalArticle

Ray, Rinki ; Herring, Christine M. ; Markel, Troy A. ; Crisostomo, Paul R. ; Wang, Meijing ; Weil, Brent ; Lahm, Tim ; Meldrum, Daniel R. / Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production. In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 2008 ; Vol. 294, No. 5.
@article{d9ac20a133a6477ca4a0b007486f4dcf,
title = "Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production",
abstract = "Modulating the paracrine effects of bone marrow mesenchymal stem cells (BMSCs) may be important for the treatment of ischemic myocardial tissue. In this regard, endogenous estrogen may enhance BMSC vascular endothelial growth factor (VEGF) production. However, little information exists regarding the effect of testosterone on stem cell function. We hypothesized that 1) endogenous or exogenous estrogen will enhance stem cell production of VEGF and 2) endogenous or exogenous testosterone will inhibit BMSC VEGF production. BMSCs were collected from adult male, female, castrated male, and ovariectomized female rats. One hundred thousand cells were incubated with testosterone (1, 10, or 100 nM) or estrogen (0.15, 1.5, or 15 nM) for 48 h. Cell supernatants were collected, and VEGF was measured by ELISA. BMSCs harvested from castrated males, normal females, and ovariectomized females produced more VEGF compared with normal males. Castration was associated with the highest level (1,018 ± 98.26 pg/ml) of VEGF production by BMSCs, which was significantly more than that produced by BMSCs harvested from normal male and normal female animals. Exogenous testosterone significantly reduced VEGF production in BMSCs harvested from ovariectomized females in a dose-dependent manner. Exogenous estrogen did not alter BMSC VEGF production. These findings suggest that testosterone may work on BMSCs to decrease protective growth factor production and that effective removal of testosterone's deleterious effects via castration may prove to be beneficial in terms of protective factor production. By manipulating the mechanisms that BMSCs use to produce growth factors, we may be able to engineer stem cells to produce maximum growth factors during therapeutic use.",
keywords = "Androgens, Castration, Estrogen, Ovariectomy, Sex, Sex hormones",
author = "Rinki Ray and Herring, {Christine M.} and Markel, {Troy A.} and Crisostomo, {Paul R.} and Meijing Wang and Brent Weil and Tim Lahm and Meldrum, {Daniel R.}",
year = "2008",
month = "5",
doi = "10.1152/ajpregu.00897.2007",
language = "English",
volume = "294",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production

AU - Ray, Rinki

AU - Herring, Christine M.

AU - Markel, Troy A.

AU - Crisostomo, Paul R.

AU - Wang, Meijing

AU - Weil, Brent

AU - Lahm, Tim

AU - Meldrum, Daniel R.

PY - 2008/5

Y1 - 2008/5

N2 - Modulating the paracrine effects of bone marrow mesenchymal stem cells (BMSCs) may be important for the treatment of ischemic myocardial tissue. In this regard, endogenous estrogen may enhance BMSC vascular endothelial growth factor (VEGF) production. However, little information exists regarding the effect of testosterone on stem cell function. We hypothesized that 1) endogenous or exogenous estrogen will enhance stem cell production of VEGF and 2) endogenous or exogenous testosterone will inhibit BMSC VEGF production. BMSCs were collected from adult male, female, castrated male, and ovariectomized female rats. One hundred thousand cells were incubated with testosterone (1, 10, or 100 nM) or estrogen (0.15, 1.5, or 15 nM) for 48 h. Cell supernatants were collected, and VEGF was measured by ELISA. BMSCs harvested from castrated males, normal females, and ovariectomized females produced more VEGF compared with normal males. Castration was associated with the highest level (1,018 ± 98.26 pg/ml) of VEGF production by BMSCs, which was significantly more than that produced by BMSCs harvested from normal male and normal female animals. Exogenous testosterone significantly reduced VEGF production in BMSCs harvested from ovariectomized females in a dose-dependent manner. Exogenous estrogen did not alter BMSC VEGF production. These findings suggest that testosterone may work on BMSCs to decrease protective growth factor production and that effective removal of testosterone's deleterious effects via castration may prove to be beneficial in terms of protective factor production. By manipulating the mechanisms that BMSCs use to produce growth factors, we may be able to engineer stem cells to produce maximum growth factors during therapeutic use.

AB - Modulating the paracrine effects of bone marrow mesenchymal stem cells (BMSCs) may be important for the treatment of ischemic myocardial tissue. In this regard, endogenous estrogen may enhance BMSC vascular endothelial growth factor (VEGF) production. However, little information exists regarding the effect of testosterone on stem cell function. We hypothesized that 1) endogenous or exogenous estrogen will enhance stem cell production of VEGF and 2) endogenous or exogenous testosterone will inhibit BMSC VEGF production. BMSCs were collected from adult male, female, castrated male, and ovariectomized female rats. One hundred thousand cells were incubated with testosterone (1, 10, or 100 nM) or estrogen (0.15, 1.5, or 15 nM) for 48 h. Cell supernatants were collected, and VEGF was measured by ELISA. BMSCs harvested from castrated males, normal females, and ovariectomized females produced more VEGF compared with normal males. Castration was associated with the highest level (1,018 ± 98.26 pg/ml) of VEGF production by BMSCs, which was significantly more than that produced by BMSCs harvested from normal male and normal female animals. Exogenous testosterone significantly reduced VEGF production in BMSCs harvested from ovariectomized females in a dose-dependent manner. Exogenous estrogen did not alter BMSC VEGF production. These findings suggest that testosterone may work on BMSCs to decrease protective growth factor production and that effective removal of testosterone's deleterious effects via castration may prove to be beneficial in terms of protective factor production. By manipulating the mechanisms that BMSCs use to produce growth factors, we may be able to engineer stem cells to produce maximum growth factors during therapeutic use.

KW - Androgens

KW - Castration

KW - Estrogen

KW - Ovariectomy

KW - Sex

KW - Sex hormones

UR - http://www.scopus.com/inward/record.url?scp=45549094779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549094779&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00897.2007

DO - 10.1152/ajpregu.00897.2007

M3 - Article

C2 - 18337309

AN - SCOPUS:45549094779

VL - 294

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 5

ER -